Which Of The Following People Was Most Likely To Die Early Due To Contact With Domesticated Animals?
Nature. 2007; 447(7142): 279–283.
Origins of major human infectious diseases
Nathan D. Wolfe
1Department of Epidemiology, School of Public Wellness, Academy of California, Los Angeles 90095-1772, USA, ,
Claire Panosian Dunavan
2Partitioning of Infectious Diseases, David Geffen Schoolhouse of Medicine, University of California, Los Angeles 90095-1688, USA, ,
Jared Diamond
3Departments of Geography and of Environmental Health Sciences, University of California, Los Angeles 90095-1524, Usa, ,
Received 2006 Sep eight; Accepted 2007 Mar 22.
- Supplementary Materials
-
Supplementary Notes This file contains all-encompassing Supplementary Notes and additional references. (PDF 924 kb)
GUID: 2225E406-8D15-48ED-952F-CFB371A8D823
Abstract
Many of the major human being infectious diseases, including some now confined to humans and absent from animals, are 'new' ones that arose only after the origins of agriculture. Where did they come from? Why are they overwhelmingly of One-time World origins? Here we show that answers to these questions are different for tropical and temperate diseases; for instance, in the relative importance of domestic animals and wild primates as sources. Nosotros identify five intermediate stages through which a pathogen exclusively infecting animals may go transformed into a pathogen exclusively infecting humans. We propose an initiative to resolve disputed origins of major diseases, and a global early warning system to monitor pathogens infecting individuals exposed to wild animals.
Supplementary data
The online version of this article (doi:10.1038/nature05775) contains supplementary cloth, which is available to authorized users.
Main
Homo hunter/gatherer populations currently suffer, and presumably have suffered for millions of years, from infectious diseases similar or identical to diseases of other wild primate populations. However, the nearly important infectious diseases of modern nutrient-producing human being populations also include diseases that could have emerged simply within the past xi,000 years, post-obit the ascension of agronomics1,2. We infer this because, as discussed beneath, these diseases tin can but be sustained in big dense human populations that did non exist anywhere in the earth earlier agriculture. What were the sources of our major infectious diseases, including these 'new' ones? Why do then many creature pathogens, including virulent viruses similar Ebola and Marburg, periodically infect human hosts but then fail to plant themselves in human populations?
A tentative before formulation1 noted that major infectious diseases of temperate zones seem to have arisen overwhelmingly in the Old World (Africa, Asia and Europe), often from diseases of Old World domestic animals. Hence ane goal of this article is to re-appraise that decision in the light of studies of the past decade. Some other goal is to extend the analysis to origins of tropical diseases3. Nosotros shall prove that they also arose mainly in the Former World, but for unlike reasons, and mostly not from diseases of domestic animals.
These results provide a framework for addressing unanswered questions nigh the evolution of human infectious diseases—questions non only of practical importance to physicians, and to all the rest of us as potential victims, but also of intellectual interest to historians and evolutionary biologists. Historians increasingly recognize that infectious diseases have had major effects on the course of history; for example, on the European conquest of Native Americans and Pacific Islanders, the disability of Europeans to conquer the One-time World torrid zone for many centuries, the failure of Napoleon's invasion of Russia, and the failure of the French attempt to complete construction of a Panama Canal4,5,6. Evolutionary biologists realize that infectious diseases, as a leading crusade of human being morbidity and mortality, accept exerted important selective forces on our genomesii,7.
We begin by defining v stages in the evolutionary transformation of an animal pathogen into a specialized pathogen of humans, and by because why so many pathogens fail to make the transition from one stage to the next. We and then gather a database of 15 temperate and 10 tropical diseases of loftier evolutionary and/or historical impact, and we compare their characteristics and origins. Our final section lays out some unresolved questions and suggests two expanded research priorities. We restrict our discussion to unicellular microbial pathogens. We exclude macroparasites (in the sense of ref. seven), as well equally normally benign commensals that cause serious illness only in weakened hosts. The all-encompassing Supplementary Information provides details and references on our 25 diseases, robustness tests of our conclusions, factors affecting transitions between disease stages, and modernistic practices altering the chance of emergence of new diseases.
Evolutionary stages
Box 1 delineates five intergrading stages (Fig. 1) through which a pathogen exclusively infecting animals (Stage i) may become transformed into a pathogen exclusively infecting humans (Stage 5). Supplementary Table S1 assigns each of the 25 major diseases discussed (Supplementary Note S1) to i of these five stages.
Illustration of the five stages through which pathogens of animals evolve to crusade diseases bars to humans.
(See Box one for details.) The four agents depicted have reached dissimilar stages in the procedure, ranging from rabies (still caused just from animals) to HIV-one (now acquired only from humans).
A big literature discusses the conditions required for a Stage 5 epidemic to persist2,seven. Briefly, if the disease infects only humans and lacks an animal or ecology reservoir, each infected human introduced into a large population of susceptible individuals must on average give rise during his/her contagious lifespan to an infection in at least one other individual. Persistence depends on factors such as the duration of a host's infectivity; the rate of infection of new hosts; charge per unit of development of host protective immunity; and host population density, size and structure permitting the pathogen's regional persistence despite temporary local extinctions.
Less well understood are two of the critical transitions between stages, discussed in Box 2. 1 is the transition from Stage 1 to Stage two, when a pathogen initially confined to animals commencement infects humans. The other is the transition from Stage 2 to Stages 3 and iv (run into also Supplementary Annotation S2), when a pathogen of animal origin that is nevertheless transmissible to humans evolves the ability to sustain many cycles of man-to-human manual, rather than just a few cycles before the outbreak dies out (as seen in modern Ebola outbreaks).
Box i: Five stages leading to endemic human being diseases
We delineate five stages in the transformation of an animal pathogen into a specialized pathogen of humans (Fig. one). There is no inevitable progression of microbes from Stage ane to Stage 5: at each phase many microbes remain stuck, and the agents of nearly half of the 25 important diseases we selected for analysis (Supplementary Tabular array S1) have not reached Stage 5.
•Stage one. A microbe that is present in animals simply that has not been detected in humans nether natural conditions (that is, excluding modern technologies that can inadvertently transfer microbes, such every bit claret transfusion, organ transplants, or hypodermic needles). Examples: nearly malarial plasmodia, which tend to be specific to one host species or to a closely related group of host species.
•Stage two. A pathogen of animals that, under natural conditions, has been transmitted from animals to humans ('chief infection') just has not been transmitted between humans ('secondary infection'). Examples: anthrax and tularemia bacilli, and Nipah, rabies and Westward Nile viruses.
•Stage 3. Fauna pathogens that can undergo only a few cycles of secondary transmission between humans, so that occasional human outbreaks triggered past a main infection before long die out. Examples: Ebola, Marburg and monkeypox viruses.
•Stage four. A disease that exists in animals, and that has a natural (sylvatic) bicycle of infecting humans by primary transmission from the brute host, but that as well undergoes long sequences of secondary transmission between humans without the involvement of animal hosts. We arbitrarily carve up Stage four into three substages distinguished past the relative importance of principal and secondary transmission: Stage 4a. Sylvatic cycle much more important than directly homo-to-human spread. Examples: Chagas' illness and (more frequent secondary transmission budgeted Stage 4b) yellow fever. Phase 4b. Both sylvatic and direct transmission are of import. Case: dengue fever in forested areas of West Africa and Southeast Asia. Stage 4c. The greatest spread is betwixt humans. Examples: influenza A, cholera, typhus and West African sleeping sickness.
•Phase five. A pathogen exclusive to humans. Examples: the agents causing falciparum malaria, measles, mumps, rubella, smallpox and syphilis. In principle, these pathogens could have become confined to humans in either of two ways: an ancestral pathogen already nowadays in the common ancestor of chimpanzees and humans could accept co-speciated long ago, when the chimpanzee and human being lineages diverged around five million years ago; or else an animal pathogen could have colonized humans more recently and evolved into a specialized human pathogen. Co-speciation accounts well for the distribution of simian foamy viruses of not-human primates, which are lacking and presumably lost in humans: each virus is restricted to 1 primate species, but related viruses occur in related primate species19. While both interpretations are yet debated for falciparum malaria, the latter interpretation of recent origins is widely preferred for most other human Phase five diseases of Supplementary Tabular array S1.
Box 2: Transitions between stages
Transition from Stage i to Phase 2. Most brute pathogens are non transmitted to humans, that is, they do not even pass from Stage 1 to Phase two. This trouble of cantankerous-species infection has been discussed previously20,21,22,23. Briefly, the probability-per-unit-fourth dimension (p) of infection of an individual of a new (that is, new recipient) host species increases with the abundance of the existing (that is, existing donor) host, with the fraction of the existing host population infected, with the frequency of 'encounters' (opportunities for transmission, including indirect 'encounters' via vectors) between an individual of the existing host and of the new host, and with the probability of transmission per encounter. p decreases with increasing phylogenetic distance between the existing host and new host. p as well varies among microbes (for example, trypanosomes and flaviviruses infect a broad taxonomic range of hosts, while plasmodia and simian foamy viruses infect only a narrow range), and this variation is related to a microbe's characteristics, such as its ability to generate genetic variability, or its ability to overcome host molecular barriers of potential new hosts (such as humoral and cellular defenses or lack of prison cell membrane receptors essential for microbe entry into host cells).
These considerations illuminate different reasons why a given brute host species may or may non become a source of many infections in humans. For case, despite chimpanzees' very low abundance and exceptional encounters with humans, they have donated to u.s. numerous zoonoses (diseases that still mainly afflict animals) and one or two established human diseases (AIDS and maybe hepatitis B) because of their close phylogenetic human relationship to humans. Despite their large phylogenetic distance from humans, many of our zoonoses and probably two of our established diseases (plague and typhus) have been caused from rodents, considering of their loftier affluence and frequent encounters with humans in dwellings. Similarly, near half of our established temperate diseases have been caused from domestic livestock, considering of high local abundance and very frequent contact. Conversely, elephants and bats are not known to accept donated direct to usa any established diseases and rarely donate zoonoses, considering they are heavily penalized on two or three counts: large phylogenetic distance, infrequent encounters with humans, and (in the case of elephants) low abundance. One might object that Nipah, astringent acute respiratory syndrome (SARS) and rabies viruses do infect humans from bats, only these apparent exceptions actually support our conclusion. While bats may indeed be the primary reservoir for Nipah and SARS, human infections by these viruses are acquired mainly from intermediate animal hosts that frequently encounter humans (respectively, domestic pigs, and wild fauna sold for nutrient). The rare cases of rabies transmission directly to humans from bats ascend because rabies changes a bat'southward behaviour so that it does see and bite humans, which a salubrious bat (other than a vampire bat) would never exercise.
Transition from Stage 2 to Stage 3 or 4. Although some Stage 2 and 3 pathogens, such as the anthrax and Marburg agents, are virulent and feared, they claim few victims at present. Yet if they made the transition to Phase 4 or 5, their global touch would exist devastating. Why do animal pathogens that accept survived the initial bound across species lines into a human host (Stages 1 to ii) usually reach a expressionless end there, and not evolve past Stages iii and 4 into major diseases confined to humans (Stage 5)? Barriers between Stages 2 and 3 (consider the rabies virus) include differences between man and animate being behaviour affecting transmission (for instance, animals oft seize with teeth humans merely humans rarely bite other humans); a pathogen's demand to evolve adaptations to the new human being host and possibly also to a new vector; and obstacles to a pathogen's spread between human tissues (for case, BSE is restricted to the central nervous organization and lymphoid tissue). Barriers between Stages 3 and 4 (consider Ebola virus) include those related to human population size and to transmission efficiency between humans. The emergence of novel pathogens is now being facilitated by modernistic developments exposing more than potential human victims and/or making manual between humans more than efficient than before24,25,26,27. These developments include blood transfusion (hepatitis C), the commercial bushmeat merchandise (retroviruses), industrial food product (bovine spongiform encephalitis, BSE), international travel (cholera), intravenous drug utilise (HIV), vaccine production (simian virus 40, SV40), and susceptible pools of elderly, antibody-treated, immunosuppressed patients (see Supplementary Note S2 for details).
Database and conclusions
Database
Supplementary Table S1 lists 10 characteristics for each of 25 important 'temperate' (fifteen) and 'tropical' (10) diseases (see Supplementary Notation S3 for details of this distinction). Our aim was to select well-divers diseases causing the highest mortality and/or morbidity and hence of the highest historical and evolutionary significance (meet Supplementary Note S1 for details of our selection criteria). Of the 25 diseases, we selected 17 because they are the ones assessed by ref. 8 as imposing the heaviest world burdens today (they have the highest inability-adapted life years (DALY) scores). Of the 17 diseases, 8 are temperate (hepatitis B, influenza A, measles, pertussis, rotavirus A, syphilis, tetanus and tuberculosis), and nine are tropical (caused allowed deficiency syndrome (AIDS), Chagas' illness, cholera, dengue haemorrhagic fever, E and W African sleeping sicknesses, falciparum and vivax malarias, and visceral leishmaniasis). We selected 8 others (temperate diphtheria, mumps, plague, rubella, smallpox, typhoid and typhus, plus tropical yellow fever) because they imposed heavy burdens in the past, although modern medicine and public wellness have either eradicated them (smallpox) or reduced their burden. Except for AIDS, dengue fever, and cholera, which have spread and attained global affect in modern times, near of these 25 diseases accept been important for more than than 2 centuries.
Are our conclusions robust to variations in these selection criteria? For about a dozen diseases with the highest mod or historical burdens (for example, AIDS, malaria, plague, smallpox), at that place can be little doubt that they must exist included, only i could debate some of the next choices. Hence we drew upwardly three alternative sets of diseases sharing a starting time listing of 16 indisputable major diseases but differing in the next choices, and we performed all 10 analyses described below on all three sets. It turned out that, with one modest exception, the 3 sets yielded qualitatively the aforementioned conclusions for all ten analyses, although differing in their levels of statistical significance (run into Supplementary Note S4). Thus, our conclusions practice seem to be robust.
Temperate/tropical differences
Comparisons of these temperate and tropical diseases yield the following conclusions:
• A higher proportion of the diseases is transmitted by insect vectors in the tropics (8/10) than in the temperate zones (2/15) (P < 0.005, χ 2-test, degrees of liberty, d.f. = ane). This difference may be partly related to the seasonal cessations or declines of temperate insect action.
• A higher proportion (P = 0.009) of the diseases conveys long-lasting immunity (xi/15) in the temperate zones than in the tropics (2/x).
• Animate being reservoirs are more than frequent (P < 0.005) in the tropics (viii/ten) than in the temperate zones (3/15). The deviation is in the reverse management (P = 0.one, NS, not meaning) for environmental reservoirs (1/10 versus 6/fifteen), merely those ecology reservoirs that do be are generally not of major significance except for soil bearing tetanus spores.
• Most of the temperate diseases (12/15) are acute rather than tiresome, chronic, or latent: the patient either dies or recovers within 1 to several weeks. Fewer (P = 0.01) of the tropical diseases are astute: 3/ten last for 1 or ii weeks, 3/10 last for weeks to months or years, and 4/10 last for many months to decades.
• A somewhat higher proportion of the diseases (P = 0.08, NS) belongs to Stage 5 (strictly confined to humans) in the temperate zones (ten/15 or xi/15) than in the tropics (three/10). The paucity of Stage 2 and Stage 3 diseases (a total of but five such diseases) on our listing of 25 major human diseases is noteworthy, because some Stage ii and Stage 3 pathogens (such as anthrax and Ebola) are notoriously virulent, and because theoretical reasons are often advanced (but also denied) as to why Stage five microbes with long histories of adaptation to humans should tend to evolve low morbidity and bloodshed and non cause major diseases. We hash out explanations for this upshot in Supplementary Notation S5.
Near (x/15) of the temperate diseases, but none of the tropical diseases (P < 0.005), are and so-chosen 'oversupply epidemic diseases' (asterisked in Supplementary Table S1), defined equally ones occurring locally equally a brief epidemic and capable of persisting regionally just in large human populations. This departure is an immediate consequence of the differences enumerated in the preceding five paragraphs. If a disease is acute, efficiently transmitted, and quickly leaves its victim either dead or else recovering and immune to re-infection, the epidemic soon exhausts the local puddle of susceptible potential victims. If in addition the disease is bars to humans and lacks meaning animal and environmental reservoirs, depletion of the local pool of potential victims in a small, sparse homo population results in local termination of the epidemic. If, all the same, the human population is large and dense, the affliction tin can persist by spreading to infect people in next areas, and so returning to the original area in a later year, when births and growth have regenerated a new ingather of previously unexposed non-immune potential victims. Empirical epidemiological studies of disease persistence or disappearance in isolated man populations of various sizes have yielded estimates of the population required to sustain a crowd disease: at to the lowest degree several hundred thousand people in the cases of measles, rubella and pertussis2,vii. But human populations of that size did non exist anywhere in the world until the steep ascent in human numbers that began around xi,000 years agone with the development of agriculture1,9. Hence the oversupply epidemic diseases of the temperate zones must have evolved since and so.
Of course, this does not mean that human hunter/gatherer communities lacked infectious diseases. Instead, like the sparse populations of our primate relatives, they suffered from infectious diseases with characteristics permitting them to persist in pocket-sized populations, unlike crowd epidemic diseases. Those characteristics include: occurrence in animal reservoirs as well as in humans (such equally yellow fever); incomplete and/or non-lasting amnesty, enabling recovered patients to remain in the pool of potential victims (such as malaria); and a slow or chronic course, enabling individual patients to proceed to infect new victims over years, rather than for merely a week or two (such as Chagas' disease).
Pathogen origins
(See details for each disease in Supplementary Note S10). Current information suggests that 8 of the fifteen temperate diseases probably or possibly reached humans from domestic animals (diphtheria, influenza A, measles, mumps, pertussis, rotavirus, smallpox, tuberculosis); three more probably reached us from apes (hepatitis B) or rodents (plague, typhus); and the other four (rubella, syphilis, tetanus, typhoid) came from still-unknown sources (run into Supplementary Annotation S6). Thus, the rise of agronomics starting 11,000 years ago played multiple roles in the evolution of animal pathogens into human pathogensi,iv,ten. Those roles included both generation of the large man populations necessary for the evolution and persistence of human crowd diseases, and generation of big populations of domestic animals, with which farmers came into much closer and more than frequent contact than hunter/gatherers had with wild animals. Moreover, equally illustrated past influenza A, these domestic animal herds served equally efficient conduits for pathogen transfers from wild animals to humans, and in the procedure may have evolved specialized crowd diseases of their own.
It is interesting that fewer tropical than temperate pathogens originated from domestic animals: not more iii of the ten tropical diseases of Supplementary Table S1, and maybe none (see Supplementary Notation S7). Why do temperate and tropical human diseases differ so markedly in their animal origins? Many (4/10) tropical diseases (AIDS, dengue fever, vivax malaria, xanthous fever) but only 1/fifteen temperate diseases (hepatitis B) take wild non-human being primate origins (P = 0.04). This is considering although not-human primates are the animals almost closely related to humans and hence pose the weakest species barriers to pathogen transfer, the vast majority of primate species is tropical rather than temperate. Conversely, few tropical but many temperate diseases arose from domestic animals, and this is because domestic animals live mainly in the temperate zones, and their concentration there was formerly even more lop-sided (run into Supplementary Annotation S8).
A final noteworthy point near animate being-derived human pathogens is that well-nigh all arose from pathogens of other warm-blooded vertebrates, primarily mammals plus in 2 cases (influenza A and ultimately falciparum malaria) birds. This comes as no surprise, considering the species barrier to pathogen transfer posed by phylogenetic altitude (Box ii). An expression of this barrier is that primates constitute only 0.5% of all vertebrate species only take contributed well-nigh twenty% of our major human diseases. Expressed in some other way, the number of major human diseases contributed, divided by the number of animal species in the taxonomic group contributing those diseases, is approximately 0.2 for apes, 0.017 for non-human being primates other than apes, 0.003 for mammals other than primates, 0.00006 for vertebrates other than mammals, and either 0 or else 0.000003 (if cholera actually came from aquatic invertebrates) for animals other than vertebrates (see Supplementary Note S9).
Geographic origins
To an overwhelming degree, the 25 major human pathogens analysed here originated in the Old World. That proved to be of dandy historical importance, because information technology facilitated the European conquest of the New World (the Americas). Far more Native Americans resisting European colonists died of newly introduced Former World diseases than of sword and bullet wounds. Those invisible agents of New World conquest were Former Earth microbes to which Europeans had both some acquired immunity based on individual exposure and some genetic resistance based on population exposure over time, but to which previously unexposed Native American populations had no immunity or resistance1,4,v,half dozen. In contrast, no comparably devastating diseases awaited Europeans in the New World, which proved to be a relatively healthy environment for Europeans until yellow fever and malaria of Sometime World origins arrived11.
Why was pathogen substitution between Old and New Worlds so unequal? Of the 25 major human diseases analysed, Chagas' illness is the but ane that conspicuously originated in the New World. For ii others, syphilis and tuberculosis, the debate is unresolved: it remains uncertain in which hemisphere syphilis originated, and whether tuberculosis originated independently in both hemispheres or was brought to the Americas by Europeans. Nil is known about the geographic origins of rotavirus, rubella, tetanus and typhus. For all of the other xviii major pathogens, Onetime Earth origins are certain or probable.
Our preceding discussion of the animal origins of human pathogens may help explicate this asymmetry. More temperate diseases arose in the Onetime Earth than New World because far more than animals that could furnish ancestral pathogens were domesticated in the Old Earth. Of the globe's 14 major species of domestic mammalian livestock, thirteen, including the five virtually arable species with which we come into closest contact (cow, sheep, caprine animal, sus scrofa and equus caballus), originated in the Old Globe1. The sole livestock species domesticated in the New Globe was the llama, merely it is not known to take infected united states of america with any pathogens1,two—peradventure considering its traditional geographic range was bars to the Andes, it was non milked or ridden or hitched to ploughs, and it was not cuddled or kept indoors (as are some calves, lambs and piglets). Among the reasons why far more than tropical diseases (nine versus one) arose in the Old World than the New Earth are that the genetic altitude between humans and New World monkeys is almost double that between humans and Former World monkeys, and is many times that between humans and Erstwhile World apes; and that much more evolutionary time was available for transfers from animals to humans in the Old Globe (about 5 million years) than in the New World (about xiv,000 years).
Outlook and future research directions
Many research directions on infectious disease origins merit more effort. We conclude by calling attention to 2 such directions: clarifying the origins of existing major diseases, and surveillance for early on detection of new potentially major diseases.
Origins of established diseases
This review illustrates big gaps in our agreement of the origins of even the established major infectious diseases. Nearly all the studies that nosotros have reviewed were based on specimens collected opportunistically from domestic animals and a few easily sampled wild animal species, rather than on systematic surveys for detail classes of agents over the spectrum of domestic and wild animals. A instance in betoken is our ignorance fifty-fifty about smallpox virus, the virus that has had peradventure the greatest impact on homo history in the by 4,000 years. Despite some noesis of poxviruses infecting our domestic mammals, we know little about poxvirus diversity among African rodents, from which those poxviruses of domestic mammals are thought to have evolved. We do not even know whether 'camelpox', the closest known relative of smallpox virus, is truly bars to camels as its name implies or is instead a rodent virus with a broad host range. There could be still-unknown poxviruses more than similar to smallpox virus in yet unstudied brute reservoirs, and those unknown poxviruses could be important not only as disease threats just also as reagents for drug and vaccine development.
Equally basic questions ascend for other major pathogens. While falciparum malaria, an infection imposing 1 of the heaviest global burdens today, seems to have originated from a bird parasite whose descendants include both the Plasmodium falciparum infecting humans and the P. reichenowii infecting chimpanzees, malaria researchers still debate whether the bird parasite was introduced to both humans and chimpanzees12 a few thousand years ago in association with human agronomics, or instead more than five 1000000 years ago before the split up of humans and chimpanzees from each other13. Although resolving this argue will not help united states eradicate malaria, information technology is fascinating in its own right and could contribute to our broader understanding of disease emergence. In the example of rubella, a man crowd disease that must take emerged just in the by 11,000 years and for which some close relative may thus still exist among animals, no even remotely related virus is known; one or more may be lurking undiscovered somewhere. Does the recent identification of porcine rubulavirus and the Mapuera virus in bats equally the closest known relatives of mumps virus mean that pigs infected humans, or that homo mumps infected pigs, or that bats independently infected both humans and pigs? Is human tuberculosis descended from a ruminant mycobacterium that recently infected humans from domestic animals (a formerly prevalent view), or from an ancient human mycobacterium that has come to infect domestic and wild ruminants (a currently popular view)?
To make full these and other yawning gaps in our agreement of disease origins, nosotros propose an 'origins initiative' aimed at identifying the origins of a dozen of the almost important homo infectious diseases: for example, AIDS, cholera, dengue fever, falciparum malaria, hepatitis B, flu A, measles, plague, rotavirus, smallpox, tuberculosis and typhoid. Although more than is already known about the origins of some of these agents (AIDS, influenza A and measles) than most others (rotavirus, smallpox and tuberculosis), more comprehensive screening is still likely to yield significant new data about fifty-fifty the most studied agents, as illustrated by the recent demonstration that gorillas rather than chimpanzees were probably the donor species for the O-grouping of human immunodeficiency virus (HIV)-one14. The proposed attempt would involve systematic sampling and phylogeographic assay of related pathogens in diverse animate being species: not but pigs and other species called for their ready availability, but a wider range of wild and domestic species whose straight contact (for example, as bushmeat) or indirect contact (for example, vector-mediated) with humans could plausibly have led to man infections. In addition to the historical and evolutionary significance of cognition gained through such an origins initiative, it could yield other benefits such as: identifying the closest relatives of human pathogens; a better understanding of how diseases have emerged; new laboratory models for studying public wellness threats; and peradventure clues that could help in predictions of futurity illness threats.
A global early warning organisation
About major human infectious diseases have animal origins, and we go on to exist bombarded by novel animal pathogens. Nonetheless there is no ongoing systematic global attempt to monitor for pathogens emerging from animals to humans. Such an effort could help us to describe the variety of microbial agents to which our species is exposed; to characterize beast pathogens that might threaten the states in the future; and maybe to detect and control a local human emergence before it has a take chances to spread globally.
In our view, monitoring should focus on people with high levels of exposure to wildlife, such as hunters, butchers of wild game, wildlife veterinarians, workers in the wild fauna trade, and zoo workers. Such people regularly get infected with animal viruses, and their infections tin be monitored over fourth dimension and traced to other people in contact with them. Ane of us (Northward.D.W.) has been working in Cameroon to monitor microbes in people who hunt wild game, in other people in their community, and in their animal preyfifteen. The study is now expanding to other continents and to monitor domestic animals (such equally dogs) that alive in close proximity to humans but are exposed to wild animals through hunting and scavenging. Monitoring of people, animals, and brute die-offs16 will serve as an early alert system for affliction emergence, while besides providing a unique annal of pathogens infecting humans and the animals to which we are exposed. Specimens from such highly exposed human populations could be screened specifically for agents known to be present in the animals they hunt (for case, retroviruses amongst hunters of non-human primates), besides as generically using broad screening tools such as viral microarrays17 and random amplification polymerase chain reaction (PCR)eighteen. Such monitoring efforts also provide potentially invaluable repositories, which would be available for study later on time to come outbreaks in order to reconstruct an outbreak'southward origin, and as a source of relevant reagents.
Supplementary information
Acknowledgements
We thank L. Krain for assistance with Supplementary Notation S10; M. Antolin, D. Shush, 50. Fleisher, E. Holmes, 50. Real, A. Rimoin, R. Weiss and Thou. Woolhouse for comments; and many other colleagues for providing data. This work was supported past an NIH Manager's Pioneer Laurels and Fogarty International Center IRSDA Award (to N.D.Westward.), a W. W. Smith Foundation laurels (to N.D.W.), and National Geographic Society awards (to J.D. and N.D.W.).
Competing interests
Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Correspondent Information
Nathan D. Wolfe, Electronic mail: ude.alcu@eflown.
Jared Diamond, Email: ude.alcu.goeg@dnomaidj.
References
1. Diamond J. Guns, Germs, and Steel: the Fates of Human Societies. 1997. [Google Scholar]
ii. Dobson AP, Carper ER. Infectious diseases and human population history. Bioscience. 1996;46:115–126. doi: 10.2307/1312814. [CrossRef] [Google Scholar]
3. Diamond J, Panosian C. When Disease Makes History: Epidemics and Keen Historical Turning Points. 2006. pp. 17–44. [Google Scholar]
4. McNeill WH. Plagues and Peoples. 1976. [Google Scholar]
5. Crosby AW. Ecological Imperialism: the Biological Expansion of Europe. 1986. pp. 900–1900. [Google Scholar]
6. Ramenofsky A. Vectors of Death: the Archaeology of European Contact. 1987. [PubMed] [Google Scholar]
7. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Command. 1991. [Google Scholar]
8. Lopez Advertizement, Mathers CD, Ezzati Northward, Jamison DT, Murray CJL. Global Burden of Disease and Run a risk Factors. 2006. [Google Scholar]
9. Bellwood P. First Farmers: the Origins of Agriculture Societies. 2005. [Google Scholar]
x. Diamond J. Evolution, consequences, and future of plant and animal domestication. Nature. 2002;418:34–41. doi: 10.1038/nature01019. [PubMed] [CrossRef] [Google Scholar]
eleven. McNeill JR. When Affliction Makes History: Epidemics and Corking Historical Turning Points. 2006. pp. 81–111. [Google Scholar]
12. Waters AP, Higgins DG, McCutchan TF. Plasmodium falciparum appears to accept arisen as a result of lateral transfer between avian and human hosts. Proc. Natl Acad. Sci. USA. 1991;88:3140–3144. doi: 10.1073/pnas.88.8.3140. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
thirteen. Ayala FJ, Escalante AA, Rich SM. Development of Plasmodium and the recent origin of the world populations of Plasmodium falciparum. Parassitologia. 1999;41:55–68. [PubMed] [Google Scholar]
14. Van Heuverswyn F, et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature. 2006;444:164. doi: 10.1038/444164a. [PubMed] [CrossRef] [Google Scholar]
15. Wolfe ND, et al. Naturally acquired simian retrovirus infections in fundamental African hunters. Lancet. 2004;363:932–937. doi: ten.1016/S0140-6736(04)15787-5. [PubMed] [CrossRef] [Google Scholar]
16. Kuiken T, et al. Pathogen surveillance in animals. Science. 2005;309:1680–1681. doi: 10.1126/science.1113310. [PubMed] [CrossRef] [Google Scholar]
17. Wang D, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol. 2003;ane:E2. doi: 10.1371/journal.pbio.0000002. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
18. Jones MS, et al. New DNA viruses identified in patients with acute viral infection syndrome. J. Virol. 2005;79:8230–8236. doi: x.1128/JVI.79.13.8230-8236.2005. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
xix. Switzer WM, et al. Ancient co-speciation of simian foamy viruses and primates. Nature. 2005;434:376–380. doi: 10.1038/nature03341. [PubMed] [CrossRef] [Google Scholar]
twenty. Taylor LH, Latham SM, Woolhouse ME. Take chances factors for human being disease emergence. Phil. Trans. R. Soc. Lond. B. 2001;356:983–989. doi: x.1098/rstb.2001.0888. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Moya A, Holmes EC, Gonzalez-Candelas F. The population genetics and evolutionary epidemiology of RNA viruses. Nature Rev. Microbiol. 2004;two:279–288. doi: x.1038/nrmicro863. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Antia R, Regoes RH, Koella JC, Bergstrom CT. The role of evolution in the emergence of infectious diseases. Nature. 2003;426:658–661. doi: 10.1038/nature02104. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
23. May RM, Gupta S, McLean AR. Communicable diseases dynamics: what characterizes a successful invader? Phil. Trans. R. Soc. Lond. B. 2001;356:901–910. doi: 10.1098/rstb.2001.0866. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
24. Morens DM, Folkers GK, Fauci Every bit. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242–249. doi: 10.1038/nature02759. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
25. Morse SS. Factors in the emergence of infectious diseases. Emerg. Infect. Dis. 1995;ane:7–15. doi: 10.3201/eid0101.950102. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
26. Wilson ME. Travel and the emergence of infectious diseases. Emerg. Infect. Dis. 1995;1:39–46. doi: x.3201/eid0102.950201. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
27. Weiss RA, McMichael AJ. Social and ecology risk factors in the emergence of infectious diseases. Nature Med. 2004;10:S70–S76. doi: ten.1038/nm1150. [PMC gratis commodity] [PubMed] [CrossRef] [Google Scholar]
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095142/
Posted by: vazquezbence1954.blogspot.com
0 Response to "Which Of The Following People Was Most Likely To Die Early Due To Contact With Domesticated Animals?"
Post a Comment